Welcome to our dedicated page for MDB Capital Holdings LLC-A news (Ticker: MDBH), a resource for investors and traders seeking the latest updates and insights on MDB Capital Holdings LLC-A stock.
MDB Capital Holdings, LLC (NASDAQ: MDBH) is an investment holding company and public venture platform in the investment banking and securities dealing industry. News and press releases about MDB Capital highlight its focus on launching early-stage and disruptive "Big Idea" companies through public venture capital, as well as developments across its subsidiaries such as MDB Capital and PatentVest.
Readers following MDBH news can expect updates on private placements, initial public offerings, and post-IPO offerings for emerging companies that align with MDB’s investment criteria. Recent announcements describe offerings and planned offerings for companies in areas such as biopharmaceuticals and consumer products, along with the expansion of MDB’s pipeline of early-stage, disruptive companies and partnerships with investor groups and registered investment advisers.
News related to PatentVest, a division of MDB Capital Holdings, features IP-focused research and strategy. PatentVest issues PatentVest Pulse reports that analyze intellectual property and competitive landscapes in sectors including quantum computing, the space economy, and cardiac diagnostics. These reports use patent data to examine leadership, defensible IP positions, and commercialization progress across innovation-driven markets.
Additional MDBH news items cover conference presentations, investor webinars, and corporate updates, including plans to spin out PatentVest as an independent public company. For investors and observers, the MDBH news feed provides insight into the company’s ongoing financings, its role in public venture capital, and its IP-centered analysis of emerging technology markets.
MDB Capital Holdings (NASDAQ: MDBH) will host a third quarter 2025 business update via Zoom webinar on Thursday, November 20, 2025 at 4:30 p.m. ET. A press release with results will be issued prior to the call. Christopher Marlett, CEO and co-founder, will lead the presentation and may be joined by other management to review developments, ongoing initiatives and anticipated milestones, followed by a question-and-answer period. Investors can pre-register for the Zoom webinar or access the live webcast on the day of the event via the company investor relations site at https://investors.mdb.com/.
PatentVest (MDBH) released a PatentVest Pulse report on Oct. 28, 2025 titled “The State of Cardiac Technology: The Path to Total Cardiac Intelligence.” The report sizes the opportunity as a $133 billion global cardiac diagnostics market and maps IP driving the shift from hospital-bound 12-lead ECGs to portable, connected systems.
Key facts: PatentVest captured 581 patent families across 243 organizations. The report highlights consumer wearables (Apple, Samsung, Google/Fitbit, Whoop, Oura, Withings, Garmin, Zepp Health, Masimo) focused on single-lead ECGs, and names innovators (HeartBeam, iRhythm, AliveCor, Mayo Clinic, Tempus AI, Eko Health, Anumana, Medical AI Co., Bodyfriend Co.). HeartBeam is cited as the first to a cable-free 12-lead ECG replication.
MDB Capital Holdings (NASDAQ: MDBH) will present at LD Micro Main Event XIX on Tuesday, October 21, 2025 at 10:30 AM PT at the Hotel del Coronado in San Diego and via virtual webcast.
Chris Marlett, CEO and co‑founder, will give the presentation. MDB noted it is the 2,000th company to present at LD Micro and said this is the firm's first presentation at a microcap conference. LD Micro Main Event XIX runs October 19–21, 2025, features ~120 companies, half‑hour presentation slots, and investor one‑on‑one meetings and receptions.
LD Micro (a subsidiary of Freedom US Markets) announced that MDB Capital Holdings (NASDAQ: MDBH) is the 2,000th company to present on its platform, according to the press release dated October 6, 2025.
The PR states LD Micro was founded in March 2006 and notes the decline in U.S. public companies from about 8,000 to ~4,000 over two decades. MDB Capital will present at the LD Micro Main Event on Tuesday, October 21, 2025 at 10:30 am, marking MDB's first microcap conference presentation.
PatentVest, a division of MDB Capital Holdings (NASDAQ: MDBH), has announced the appointment of Dr. Sarah Cork as Senior Patent Attorney. Dr. Cork brings over a decade of experience in biotechnology, pharmaceutical, and medical device intellectual property matters, complemented by a Ph.D. in Neuroscience.
Dr. Cork specializes in complex IP matters including recombinant technology, biologics, immunotherapies, gene therapy, and AI-enabled precision medicine. Her expertise spans patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses, with significant experience in BPCIA cases and Hatch-Waxman matters.
Beyond her legal practice, Dr. Cork serves as President of the Los Angeles Intellectual Property Law Association and is active in the Pasadena Angels investor group and SBIR grant review process.
MDB Capital Holdings (NASDAQ: MDBH), a public venture platform, has provided its Q2 2025 operational update highlighting several key developments. The company announced a private offering for Paulex Bio, which is developing an oral diabetes medication, and filed an S-1 for Buda Juice's IPO.
Notable developments include a strategic partnership with Keiretsu Forum MST for the IPO Angels platform and plans to spin out PatentVest as an independent public company in 2026. MDB is strengthening its position in public markets while expanding relationships with RIAs to reach investors seeking venture exposure.
PatentVest and Docana (MDBH) have announced a strategic partnership focused on integrating IP strategy and AI innovation. Under the agreement, PatentVest will provide strategic legal and IP consulting services to protect Docana's technology portfolio, while gaining access to Docana's next-generation AI platform.
The partnership aims to enhance both companies' capabilities: PatentVest will help Docana develop comprehensive IP protection strategies, while Docana's AI platform will optimize PatentVest's internal knowledge workflows. This collaboration demonstrates how AI technology can transform IP strategy services while ensuring proper protection for AI innovations.
PatentVest has released its groundbreaking Quantum Computing Pulse Report, analyzing leadership in the emerging $850B quantum computing market. The comprehensive study evaluated 38 companies across various metrics and analyzed 14,762 patent families from 1,743 assignees.
The report reveals three distinct leaders in the startup space: D-Wave Quantum (1,338 publications), Origin Quantum (1,326 publications), and IonQ Inc. (1,224 publications). In the corporate landscape, IBM leads with 1,860 publications, followed by Alphabet (1,223) and Origin Quantum (1,040).
The analysis indicates that quantum computing is transitioning from R&D to commercialization, with success depending on both defensible intellectual property and commercialization capabilities.
MDB Capital Holdings (NASDAQ: MDBH), a public venture platform specializing in disruptive technology companies, has scheduled a Q2 2025 business update conference call for August 27, 2025, at 4:30 p.m. ET. The call will be hosted via Zoom webinar.
CEO and Co-Founder Christopher Marlett will lead the presentation, potentially joined by other management team members. The discussion will cover recent developments, ongoing initiatives, and upcoming milestones, followed by a Q&A session. A press release with detailed Q2 2025 results will be issued before the call.
PatentVest has released a comprehensive report titled "The Next Era of Surgical Robotics" analyzing the $188B surgical robotics market. The report, based on analysis of 18,000+ patent families and $4B in M&A activity, reveals that despite 310 million annual global surgeries, only 6% involve robots.
The study examines 28 robotic platforms and identifies key market players, including Intuitive Surgical as the dominant patent holder, legacy incumbents like Medtronic and Johnson & Johnson, and emerging challengers such as Vicarious Surgical and CMR Surgical. The report highlights how venture-backed platforms are positioning themselves for strategic scale, following the path of successful acquisitions like MAKO, Auris, and Mazor.